Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.850
-0.060 (-2.06%)
At close: Nov 22, 2024, 4:00 PM
2.940
+0.090 (3.16%)
After-hours: Nov 22, 2024, 7:21 PM EST
Sonoma Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for SNOA.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for SNOA.
Recommendation Trends
Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +2,180.70% | Sep 5, 2023 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 6, 2018 |
Maxim Group | Maxim Group | Strong Buy Maintains $1,800 → $1,980 | Strong Buy | Maintains | $1,800 → $1,980 | +69,373.68% | Nov 10, 2017 |
Financial Forecast
Revenue This Year
17.32M
from 12.74M
Increased by 36.00%
Revenue Next Year
21.70M
from 17.32M
Increased by 25.26%
EPS This Year
-4.08
from -10.64
EPS Next Year
-1.84
from -4.08
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 17.8M | 22.3M |
Avg | 17.3M | 21.7M |
Low | 16.6M | 20.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 40.0% | 28.9% |
Avg | 36.0% | 25.3% |
Low | 30.7% | 20.4% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -4.20 | -1.89 |
Avg | -4.08 | -1.84 |
Low | -3.92 | -1.76 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.